Related Experiment Video
Updated: Jan 27, 2026
06:45
Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP
Published on: June 15, 2018
8.0K
Complement component 1q subcomponent binding protein in the brain of the rat.
János Barna1, Diána Dimén2, Gina Puska2
1Department of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary.
Scientific Reports
|March 16, 2019
Summary
Complement component 1q subcomponent binding protein (C1qbp) is found in specific rat brain neurons, particularly within mitochondria. This suggests a role in regulating neuronal energy supply.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Complement component 1q subcomponent binding protein (C1qbp) is a multifunctional protein with roles in immunity and cellular energy.
- Emerging evidence suggests C1qbp may also be involved in neuronal functions like axon maintenance and synaptic plasticity.
Purpose of the Study:
- To identify the distribution and localization of C1qbp in the adult rat brain.
- To investigate the cellular and subcellular localization of C1qbp in neurons and glial cells.
- To explore the potential role of C1qbp in neuronal energy homeostasis.
Main Methods:
- In situ hybridization histochemistry to detect C1qbp mRNA.
- Immunolabeling at light and electron microscopy levels to visualize C1qbp protein.
- Double labeling with neuronal, glial, and mitochondrial markers.
- Induction of focal ischemic lesions to study C1qbp in activated microglia.
Main Results:
- C1qbp exhibits a distinct topographical distribution in the rat brain, with high abundance in the cerebral cortex and specific hypothalamic and thalamic nuclei.
- C1qbp is primarily localized in neurons, but also appears in activated microglia following ischemic injury.
- Mitochondrial localization of C1qbp was confirmed in neurons, with variations in mitochondrial content across brain regions and within individual neurons.
Conclusions:
- C1qbp is specifically expressed in a subset of neurons in the rat brain, with a significant mitochondrial localization.
- These findings suggest a specialized function for C1qbp in brain, potentially related to the regulation of energy supply within neuronal mitochondria.
Related Concept Videos
01:30Drug Binding to Blood Components
526
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
526
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
547
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
547
01:27Complement System
10.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.4K
02:18The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
00:49Complementation Tests
6.2K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.2K
01:22Protein-Drug Binding: Determination Methods
646
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
646